AzTrials
AzTrials

Pressure UlcerNCT02348294

The Effect of Shear- Force at the Skin in Patients With Diabetes Mellitus

A study testing Shear- force 19 newton and 3,9 kpa pressure for half an hour in people with Pressure Ulcer and Diabetes Mellitus Type 2, run by Maastricht University Medical Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. The objective of this study is to acquire knowledge about the development of reactive hyperaemia and inflammatory responses of the skin after shear- force and pressure loading. We want to investigate if patients with diabetes type 2 will develop more skin damage, because of a decreased microvascular function. 2. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
What is being tested?
Shear- force 19 newton and 3,9 kpa pressure for half an hour
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Feb 2015to Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Group A:
  • Healthy volunteers
  • > 40 years
  • Group B;
  • patients with Diabetes Mellitus type 2 (DM) without neuropathy
  • age > 40 years
Show all 15Show fewer
  • Valk score < 4
  • Group C:
  • Patients with DM type 2 with neuropathy
  • age > 40 years
  • Valk score > 4
  • Group D
  • Patients with (pre)- existing Charcot Osteoarhtropathy
  • age > 40 years
  • Valk score > 4

Who cannot join

  • Trauma fore arms
  • Skin diseases (psoriasis, eczema)
  • NSAID use in last seven days
  • Bèta blocker use
  • Corticosteroids
  • Auto- immune diseases
Show all 11Show fewer
  • Muscular dystrophy
  • Malignancy
  • Participant is unable to give informed consent
  • Peripheral artery disease (doppler eai <0.9)
  • Hab1c percentage last 3 months > 11%

Trial locations and contacts

No sites are listed yet.

Luuk de Wert, MD contact

+31618074833

luuk.wertde@mumc.nl

About this study

Official title: Measurement of Cytokines, Bloodflow and Erythema Index After Pressure and Shear- Force Loading in Patients With Diabetes Mellitus Type 2

  1. The objective of this study is to acquire knowledge about the development of reactive hyperaemia and inflammatory responses of the skin after shear- force and pressure loading. We want to investigate if patients with diabetes type 2 will develop more skin damage, because of a decreased microvascular function.
  2. The second objective of this study is: to investigate if the cytokine production of the skin is increased in patients with type 2 diabetes with a history of Charcot osteoarthropathy in comparison with patients with neuropathy without a history of Charcot osteoarthropathy.

The participant is asked to put his left arm on a support cushion. Then we mark an area of 2.5 cm x 3 cm with a permanent marker at the plantar aspect of the left fore-arm and the adhesive side of a Sebutape is placed within this area for collection of IL-1α/ total protein concentrations in a non- loaded situation (event 1) for two minutes. Second, we measure the cutaneous blood cell flux within the borders of the marked area with a Laser doppler. Finally, we measure the erythema index in this area with a colorimeter. Then we place the shear- pad over the marked area we apply 9,8 Newton (N) pressure with 19 N shear- force for half an hour. After this period a new Sebutape is placed for two minutes, followed by cutaneous blood cell flux and the erythema index measurement within the borders of the marked area. We repeat these measures after 15 minutes, 30 minutes, 45 minutes and 60 minutes, At the same time we performed the same experiment at the right arm, but instead of loading this arm with shear- force and pressure, we apply only 9,8 N pressure at this arm. The same measures with the sebutape, laser doppler and colorimeter are done before and after loading of the skin. The measures are repeated at 15 minutes, 30 minutes, 45 minutes and 60 minutes.

Read the detailed description
  1. Pressure ulcers, also known as bedsores occurs as a result of mechanical loading (combination of pressure and shear- force) of the skin. We proved that IL-1alpha (measurement of skin damage) and reactive hyperaemia (RH) are increased after a combined loading of pressure and shear- force with our own developed shear- force model. This RH is probably a protective mechanism of the loaded skin and is clinically seen as blanchable erythema. Blanchable erythema is seen as an important risk indicator for the development of pressure ulcers. Patients with Diabetes Mellitus type 2, however, will develop less blanchable erythema (RH), because of a decreased micro vascular function. Therefore, they will get less preventive measures against pressure ulcers. We do expect, however, that more skin damage occurs when RH is decreased, so we want to investigate if patients with type 2 diabetes (with or without neuropathy) will develop less RH and more skin damage (IL-1alpha) after shear force application at the skin compared with healthy volunteers.
  2. Charcot- neuro- osteoarthropathy is a rare, but serious complication of polyneuropathy. Most of the times it occurs at the feet in patients with diabetes with neuropathy. It is associated with inflammation, hyperaemia, bone deformation and luxation of the joints. The pathogenesis is not well understood: the hyperemic response of the skin to external stimuli is increased, but we do not know if this hyperaemia is a result of primary hypervascularity or a increase in primary cytokines. Our research model gives us the opportunity to investigate if: the local cytokine production is increased in patients with diabetes type with neuropathy and a history of charcot osteoarthropathy after shear- force application at the skin compared with patients with type 2 diabetes with neuropathy.

Study population:

Group A:

  • Healthy volunteers
  • > 40 years

Group B;

  • patients with Diabetes Mellitus type 2 (DM) without neuropathy
  • age > 40 years
  • Valk score < 4

Group C:

  • Patients with DM type 2 with neuropathy
  • age > 40 years
  • Valk score > 4

Group D

  • Patients with (pre)- existing Charcot Osteoarhtropathy
  • age > 40 years
  • Valk score > 4 Primary study parameters/outcome of the study
  1. IL-1 α/ total protein ratio
  2. Bloodflow of the skin (in flux )
  3. Erythema index of the skin

The participant is asked to put his left arm on a support cushion. Then we mark an area of 2.5 cm x 3 cm with a permanent marker at the plantar aspect of the left fore-arm and the adhesive side of a Sebutape is placed within this area for collection of IL-1α/ total protein concentrations in a non- loaded situation (event 1) for two minutes. Second, we measure the cutaneous blood cell flux within the borders of the marked area with a Laser doppler. Finally, we measure the erythema index in this area with a colorimeter. Then we place the shear- pad over the marked area we apply 9,8 Newton (N) pressure with 19 N shear- force for half an hour. After this period a new Sebutape is placed for two minutes, followed by cutaneous blood cell flux and the erythema index measurement within the borders of the marked area. We repeat these measures after 15 minutes, 30 minutes, 45 minutes and 60 minutes, At the same time we performed the same experiment at the right arm, but instead of loading this arm with shear- force and pressure, we apply only 9,8 N pressure at this arm. The same measures with the sebutape, laser doppler and colorimeter are done before and after loading of the skin. The measures are repeated at 15 minutes, 30 minutes, 45 minutes and 60 minutes.

Outcomes; IL-1alpha/ total protein- ratio Cutaneous blood cell flux Erythema index

Being tested
Shear- force 19 newton and 3,9 kpa pressure for half an hour
Medical subject headings
Pressure Ulcer, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shear- force 19 newton and 3,9 kpa pressure for half an hourOther

Study groups in NCT02348294
Study groupRoleWhat they receive
Healthy volunteersOtherShear- force 19 newton and 3,9 kpa pressure for half an hour
Receives: Other: Shear- force 19 newton and 3,9 kpa pressure for half an hour
Diabetes Mellitus type 2 without neuropathyOtherShear- force 19 newton and 3,9 kpa pressure for half an hour
Receives: Other: Shear- force 19 newton and 3,9 kpa pressure for half an hour
Diabetes Mellitus type 2 with neuropathyOtherShear- force 19 newton and 3,9 kpa pressure for half an hour
Receives: Other: Shear- force 19 newton and 3,9 kpa pressure for half an hour
Charcot OsteoarhtopathyOtherShear- force 19 newton and 3,9 kpa pressure for half an hour
Receives: Other: Shear- force 19 newton and 3,9 kpa pressure for half an hour

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Increase in IL-1alpha/ total protein ratio

    Measured: 0, 15, 30, 45, 60 minutes after intervention

  2. Increase in Cutaneous blood cell flux

    Measured: 0, 15, 30, 45, 60 minutes after intervention

  3. Increase in erythema index

    Measured: 0, 15, 30, 45, 60 minutes after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2015 (estimated)
  2. Study startFeb 2015
  3. Primary completionJan 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02348294
Sponsor's protocol ID
NL50794.068.14
Status last verified
Jan 2015
First submitted
22 Jan 2015
Last updated
28 Jan 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Shear- force 19 newton and 3,9 kpa pressure for half an hour in people with Pressure Ulcer and Diabetes Mellitus Type 2, run by Maastricht University Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Luuk de Wert, MD (+31618074833, luuk.wertde@mumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Increase in IL-1alpha/ total protein ratio (time frame: 0, 15, 30, 45, 60 minutes after intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in